Non-Hodgkin Lymphoma Program
Our Innovative Approach
Research & clinical trials
The Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) is a part of the Children’s Oncology Group (COG), a national cancer research consortium. Children's Oncology Group studies include:
- therapeutic trials for newly diagnosed patients
- access to investigational drug therapy at the time of relapse
- biologic studies of lymphoma
- studies to improve the supportive care of patients undergoing treatment
It’s possible that your child will be eligible to participate in one of our current clinical trials. These studies are useful for many reasons: Some trials are designed to evaluate the effectiveness of a particular drug, treatment or therapy on a specific disease; others help doctors to better understand how and why certain conditions occur.
These trials are available through independent investigators at DF/CHCC and through the Children’s Oncology Group. At any given time, Children’s has hundreds of clinical trials underway.
Participation in any clinical trial is completely voluntary: We will take care to fully explain all elements of the treatment plan prior to the start of the trial, and you may remove your child from the medical study at any time.
To search the NIH’s list of clinical trials taking place around the world, go to: http://www.clinicaltrials.gov/ct2/search
Survivorship & long-term care
Like all patients who were treated with chemotherapy and/or radiation, survivors of childhood non-Hodgkin lymphoma may be at risk of developing problems or side effects later in life.
To help patients monitor their overall health after they’re finished with treatment, we encourage children and adolescents to continue long-term care through our David B. Perini Jr. Quality of Life Clinic. At this clinic, experts assess childhood cancer survivors of all ages for hormonal evaluation and treatment and dental evaluation and treatment, among others.
For more information about the David B. Perini Jr. Quality of Life Clinic, click here.